Online inquiry

IVTScrip™ mRNA-Human ARL1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK23232MR)

This product GTTS-WK23232MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARL1 protein. This product can be used in SLC16A7+ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001177.6
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 400
UniProt ID P40616
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARL1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK23232MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK5327MR IVTScrip™ mRNA-Human CD24, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA CD24
GTTS-WK18563MR IVTScrip™ mRNA-Human ANXA5, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANXA5
GTTS-WK23292MR IVTScrip™ mRNA-Human ASAP2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASAP2
GTTS-WK21207MR IVTScrip™ mRNA-Human ANKRD20A12P, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANKRD20A12P
GTTS-WK25643MR IVTScrip™ mRNA-Human ARL4D, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARL4D
GTTS-WK2385MR IVTScrip™ mRNA-Human FSHR, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA FSHR
GTTS-WK23004MR IVTScrip™ mRNA-Human ASCC3, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ASCC3
GTTS-WK8654MR IVTScrip™ mRNA-Human ADIPOR2, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ADIPOR2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →